H.R. 5646, the Restoring Safeguards for Dangerous Abortion Drugs Act, would reverse recent FDA regulatory changes to mifepristone, a medication used for medication abortion. Within 90 days of enactment, the bill requires the Secretary of Health and Human Services to withdraw the current safety requirements for mifepristone and reinstate the stricter risk management rules that were in place in June 2011, preventing any future modifications to those earlier standards. The legislation also bans the importation of mifepristone into the United States by any person, including through mail delivery. Additionally, it creates a federal civil liability provision allowing individuals to sue telehealth providers, pharmacies, and other entities that import or transport mifepristone in violation of federal law, with the ability to recover compensatory damages, punitive damages, and attorney's fees—a private right of action that takes effect 90 days after the bill's enactment. This bill would significantly restrict access to medication abortion across the country.